TScan Therapeutics
TCRX
#9373
Rank
โ‚ฌ56.78 M
Marketcap
1,00ย โ‚ฌ
Share price
-9.09%
Change (1 day)
-84.65%
Change (1 year)

P/S ratio for TScan Therapeutics (TCRX)

P/S ratio as of April 2025 (TTM): 23.1

According to TScan Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.2701. At the end of 2024 the company had a P/S ratio of 58.0.

P/S ratio history for TScan Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202458.0337.83%
202313.2380.36%
20222.76-74.01%
202110.6